TNXP - トニックス・ファ―マシュ―ティカルズ (Tonix Pharmaceuticals Holding Corp.)

TNXPのニュース

   Tonix Pharma expects late-stage RELIEF trial results ahead of schedule (NASDAQ:TNXP)  2020/06/29 12:52:35 Seeking Alpha
Due to faster-than-expected enrollment, Tonix Pharmaceuticals Holding (NASDAQ:TNXP) anticipates topline Phase 3 RELIEF results in Q4 2020, rather than Q1 2
   Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences  2020/06/03 11:00:00 GlobeNewswire
NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Company…
   Tonix To Develop Vaccine Against COVID-19 Virus, Shares Surge  2020/02/26 14:46:04 Benzinga
Shares of micro-cap biotech Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) are surging Wednesday morning. The New York-based company announced a strategic collaboration with Southern Research to support development of a vaccine, codenamed TNX-1800, a live modified horsepox virus vaccine for percutaneous administration, to protect against COVID-19. TNX-1800 is modified from its TNX-801, a live horsepox virus vaccine for percutaneous administration, which is in pre-clinical development … Full story available on Benzinga.com
   Tonix Pharmaceuticals down 60% premarket on failed Tonmya study  2020/02/06 11:44:23 Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) has decided to stop enrollment in a Phase 3 clinical trial, RECOVERY, evaluatinng Tonmya (cyclobenzaprine HCl sublingua
   Tonix Pharma up 42% premarket on advancement of TNX-102 SL  2020/01/24 12:15:26 Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) has completed fed-fasting and dose proportionality tests of TNX-102 SL in healthy volunteers, data that, it says, shoul
   Tonix Pharma expects late-stage RELIEF trial results ahead of schedule (NASDAQ:TNXP)  2020/06/29 12:52:35 Seeking Alpha
Due to faster-than-expected enrollment, Tonix Pharmaceuticals Holding (NASDAQ:TNXP) anticipates topline Phase 3 RELIEF results in Q4 2020, rather than Q1 2
   Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences  2020/06/03 11:00:00 GlobeNewswire
NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Company…
   Tonix To Develop Vaccine Against COVID-19 Virus, Shares Surge  2020/02/26 14:46:04 Benzinga
Shares of micro-cap biotech Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) are surging Wednesday morning. The New York-based company announced a strategic collaboration with Southern Research to support development of a vaccine, codenamed TNX-1800, a live modified horsepox virus vaccine for percutaneous administration, to protect against COVID-19. TNX-1800 is modified from its TNX-801, a live horsepox virus vaccine for percutaneous administration, which is in pre-clinical development … Full story available on Benzinga.com
   Tonix Pharmaceuticals down 60% premarket on failed Tonmya study  2020/02/06 11:44:23 Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) has decided to stop enrollment in a Phase 3 clinical trial, RECOVERY, evaluatinng Tonmya (cyclobenzaprine HCl sublingua
   Tonix Pharma up 42% premarket on advancement of TNX-102 SL  2020/01/24 12:15:26 Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) has completed fed-fasting and dose proportionality tests of TNX-102 SL in healthy volunteers, data that, it says, shoul
   Tonix Pharmaceuticals to Participate in Two June Virtual Investor Conferences  2020/06/03 11:00:00 GlobeNewswire
NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) announced today that Company…
   Tonix To Develop Vaccine Against COVID-19 Virus, Shares Surge  2020/02/26 14:46:04 Benzinga
Shares of micro-cap biotech Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP ) are surging Wednesday morning. The New York-based company announced a strategic collaboration with Southern Research to support development of a vaccine, codenamed TNX-1800, a live modified horsepox virus vaccine for percutaneous administration, to protect against COVID-19. TNX-1800 is modified from its TNX-801, a live horsepox virus vaccine for percutaneous administration, which is in pre-clinical development … Full story available on Benzinga.com
   Tonix Pharmaceuticals down 60% premarket on failed Tonmya study  2020/02/06 11:44:23 Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) has decided to stop enrollment in a Phase 3 clinical trial, RECOVERY, evaluatinng Tonmya (cyclobenzaprine HCl sublingua
   Tonix Pharma up 42% premarket on advancement of TNX-102 SL  2020/01/24 12:15:26 Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) has completed fed-fasting and dose proportionality tests of TNX-102 SL in healthy volunteers, data that, it says, shoul
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.

calendar